Taysha Gene Therapies, Inc.
Taysha Gene Therapies develops AAV-based gene therapies for severe monogenic central nervous system diseases.
SCHEDULE 13G/AAug 14Latest SEC filing
Aug 11Latest story
August 2026
Sign inSign inTaysha Gene Therapies develops AAV-based gene therapies for severe monogenic central nervous system diseases.